Digital Program Helps Manage Weight Gain in Pregnant Women With Overweight or Obesity
Tests a digital weight gain program in pregnant women with overweight or obesity.
Key facts
- Who runs it
- Penn State University
- Where
- University Park, United StatesSee the site
- Trial code
- Registry title
- Healthy Mom Zone Gestational Weight Gain Management Intervention 2.0
- Status
- Recruiting
- People taking part
- 144 people, planned
- Started
- 27 Nov 2023
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- HMZ 2.0 Intervention
- Attention Control Intervention
- Record updated
- 16 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women aged 18-45 with overweight or obesity, in early pregnancy, to test a program that manages weight gain during pregnancy.
- Age
- 18-45 years
- Sex
- Women only
- Disease stage
- Pregnant at 8 to under 18 weeks at screening, with a single baby. BMI 20.0 to 45.0. Not more than 25% of the total pregnancy weight gain advised by the guidelines (BMI and IOM) already gained. BMI over 40 needs the health care provider's agreement.
- Earlier treatment
- No current use of weight loss medications. No planned weight loss (bariatric) surgery during this pregnancy. No current participation in another study or program that affects weight control.
Main reasons for not taking part
- Pregnant with more than one baby
- Smoking more than 20 cigarettes a day
- Cannot read or understand English, or has no computer or phone access
- Conditions that make exercise in pregnancy unsafe, such as significant heart disease, preeclampsia or placenta previa after 26 weeks
- Current eating disorder diagnosis or poorly controlled conditions such as severe asthma, seizure disorder or thyroid disease
This trial only enrols pregnant participants. The registry sentence this rests on: Pregnant women
The registry criteria, word for word
Show all 56 criteriaShow less
Who can take part
- Pregnant women
- ≥ 8 and < 18 weeks gestation at time of screening. This range of gestational age is chosen to: a) reduce chances of false pregnancy or miscarriage under 8 weeks gestation and b) recruit women in the 1st trimester for greatest impact of the intervention on gestational weight gain. In the feasibility and initial impact study, the investigators had less than 10% (n=3) miscarriages prior to randomization using these criteria
- Singleton gestation
- Not currently heavily smoking (>20 cigarettes/day)
- Any parity (i.e., first-time pregnancy, second pregnancy, etc.)
- Any race/ethnicity
- Ages 18-45 years
- Body mass index (BMI) range 20.0 to 45.0. If BMI is over 40, consultation with woman's health care provider will be made to determine eligibility and ensure she does not have any contraindications to physical activity or other concerns with intervention participation
- Haven't exceeded 25% or more of their total GWG (based on BMI and IOM guidelines) from pre-pregnancy to date of enrollment
- Participant has physician consent to confirm subject participation
- Able to read, understand, and speak English
- Access to a computer/phone
- Willingness and ability to complete study materials and intervention sessions electronically (e.g., email, Facetime, Zoom), at home (e.g., Zoom sessions delivered synchronous and asynchronous) or if requested by the participant, on-site at Penn State University Park or Hershey campuses
- No current use of weight loss medications
- No current participation in another interventional study or program that influences weight control
- No planned bariatric surgery during this current pregnancy
- No absolute contraindications to exercise in pregnancy and relative contraindications with provider consent (see below)
Who cannot take part
- Current use of weight loss medications
- Planned bariatric surgery during this current pregnancy
- Hemodynamically significant heart disease
- Restrictive lung disease (pulmonary fibrosis, sarcoidosis, pleural effusion, neuromuscular disease). This DOES NOT include ASTHMA
- Persistent 2nd or 3rd trimester bleeding
- Poorly controlled chronic hypertension
- Poorly controlled Type 1 diabetes; Relative contraindications to exercise (if permission is not given by provider):
- Unevaluated maternal cardiac arrhythmia
- History of extremely sedentary lifestyle
- Current eating disorder(s) diagnosis
- Severe food allergies and/or dietary restrictions that may preclude study participation
- Poorly controlled respiratory disorder (severe asthma) that precludes study participation
- Poorly controlled seizure disorder
- Poorly controlled thyroid disease
- Uncontrolled sleep disorder (insomnia, sleep-disordered breathing)
- Outside of the age range of 18-45 years
- Not pregnant women
- Men (unable to become pregnant)
- Multiple gestation
- < 8 weeks gestation or > 18 weeks gestation at time of pre-intervention assessment
- Currently smoking > 20 cigarettes/day
- Outside of the BMI range of 20.0-45.0
- Exceeded 25% of their total GWG (based on BMI and IOM guidelines) from pre-pregnancy to date of enrollment
- Not able to read and/or understand English
- Unable to access materials by computer or phone (even with data plan assistance if necessary)
- Current participation in another interventional study or program that influences weight control
- Contraindications to aerobic exercise in pregnancy:; Absolute contraindications to exercise:
- Incompetent cervix/cerclage
- Severe anemia
- Multiple gestation at risk for premature labor
- Placenta previa after 26 weeks gestation
- Premature labor during the current pregnancy
- Ruptured membranes
- Preeclampsia diagnosis during current pregnancy
- Chronic bronchitis
- Extreme morbid obesity (BMI > 40.0; needs provider consent to participate)
- Extreme underweight (BMI < 12.0)
- Intrauterine growth restriction in current pregnancy
- Orthopedic limitations
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Where in United States
- Pennsylvania State UniversityUniversity Park, United StatesContact: Abigail M Pauley, PhDTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to see if the enhanced HMZ 2.0 intervention with new control system/digital platform to regulate gestational weight gain (GWG) and impact maternal-infant outcomes while collecting implementation data works and can be given to other pregnant women in various settings. The question this study aims to answer are:
Read full original descriptionShow less
1. Does the new intervention manage GWG? 2. Does the new intervention have any influence on sleep and eating behaviors and infant outcomes. 3. Does the new platform and other data collected help inform how well the research and information can be used in health care settings?
144 pregnant women with overweight/obesity will be randomized to either the HMZ 2.0 intervention or attention control groups from ~8-36 weeks gestation. All participants will be asked to:
1. Weight themselves and wear an activity monitor each day over the study. 2. Complete online surveys at either a weekly or monthly level about their thoughts, attitudes, and behaviors on GWG, physical activity, eating behaviors, sleep, their anxiety, depression, and stress. 3. Attend weekly sessions with a registered dietician.
The weekly sessions will differ based on intervention group. The HMZ 2.0 intervention group will receive education, create and follow goal-setting and action plans, self-monitor their behaviors, and receive feature evidence and fetal growth facts. Education, goals, and self-monitoring will focus on GWG, physical activity, eating behaviors, sleep, self-regulating behaviors and emotions, and preparing for labor/delivery and postpartum.
The attention control group will receive weekly sessions on preparing for labor/delivery and benefits of behavioral pain management strategies (e.g., mindfulness-based relaxation, imagery, music, massage, deep-breathing) to help with pain after childbirth without medicine.
The 2 groups in the trial
- HMZ 2.0 Intervention GroupTreatment being tested
HMZ 2.0 will be delivered by a registered dietitian in weekly didactic, one-on-one discussions in remote synchronous format (e.g., Zoom). If a subject has internet connectivity issues, she will be able to participate in the remote sessions from an onsite location (e.g., laboratory space on the Penn State University Park campus, clinical space at Hershey campus or Geisinger). All intervention women will receive the baseline intervention delivered as a maximum of 24 weekly modules (depending on gestational age at enrollment) which includes: Education and Counseling (GWG/PA/EI/sedentary behaviors/sleep behaviors/stress management, etc.), Goal-Setting and Action Plans (guided and self-selected PA/EI goals including recipe and workout booklet use), Self-Monitoring (wearing/using mHealth tools to monitor GWG/PA/EI/sleep), and Featured Evidence and Fetal Growth Facts (evidence-based studies and baby growth fun facts shared with women about how mom's health impacts her baby).
Treatment: HMZ 2.0 Intervention
- Attention Control GroupExisting treatment, for comparison
All women will receive prenatal care offered by recruitment sites with routine provider visits, prenatal counseling, brief discussions on healthy prenatal behaviors, and clinical oversight of health (e.g., monitor glucose levels if diagnosed with gestational diabetes during the study period). Women randomized to the attention control group will complete the same measurement procedures as the intervention group. To match the HMZ intervention group, women will receive weekly, remote-delivered education content (60 min/session) on preparing for labor/delivery and benefits of behavioral pain management strategies (e.g., mindfulness-based relaxation, imagery, music, massage, deep-breathing) to regulate pain after childbirth with non-pharmacological approaches. Content is drawn from evidence-based guidelines and materials designed by Dr. Downs and her team for a Patient-Provider Toolbox to reduce opioid-related pain management use after childbirth.
Treatment: Attention Control Intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Efficacy of a Novel Digital Platform to Scale-Up a Personalized Prenatal Weight Gain Intervention Using Control Systems Methodology
- Plain-language title
- Digital Program Helps Manage Weight Gain in Pregnant Women With Overweight or ObesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05807594, who can take part
- Record updated
- 16 January 2026